Bio-Rad Laboratories (BIO) Gross Profit (2016 - 2025)
Bio-Rad Laboratories (BIO) has disclosed Gross Profit for 17 consecutive years, with $345.2 million as the latest value for Q4 2025.
- Quarterly Gross Profit rose 0.94% to $345.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2025, down 2.83% year-over-year, with the annual reading at $1.3 billion for FY2025, 2.83% down from the prior year.
- Gross Profit for Q4 2025 was $345.2 million at Bio-Rad Laboratories, up from $343.4 million in the prior quarter.
- The five-year high for Gross Profit was $436.5 million in Q3 2021, with the low at $306.0 million in Q1 2025.
- Average Gross Profit over 5 years is $367.6 million, with a median of $362.4 million recorded in 2023.
- The sharpest move saw Gross Profit skyrocketed 36.89% in 2021, then dropped 14.64% in 2022.
- Over 5 years, Gross Profit stood at $399.9 million in 2021, then dropped by 0.7% to $397.1 million in 2022, then dropped by 7.76% to $366.3 million in 2023, then fell by 6.63% to $342.0 million in 2024, then grew by 0.94% to $345.2 million in 2025.
- According to Business Quant data, Gross Profit over the past three periods came in at $345.2 million, $343.4 million, and $345.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.